5/9/2025

Janusmed kön och genus

Janusmed kön och genus – cytisiniklin

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
A A
A A

Cytisiniklin

Cytisiniklin

Klass : A

Visa all info

Skriv ut

Kontakta oss

  1. Manns A, Torregrossa H, Mahdjoub S, Gomajee R, Melchior M, El-Khoury Lesueur F. Do Determinants of Smoking Cessation and Relapse Differ between Men and Women? Data from a French National Study. Subst Use Misuse. 2024;59(2):167-176.

  2. Swan GE, Javitz HS, Jack LM, Curry SJ, McAfee T. Heterogeneity in 12-month outcome among female and male smokers. Addiction. 2004;99:237-50.

  3. Kuo CW, Lin CF, Chen CY, Wang RH, Chou CY, Cheng HJ et al. Body-Weight Gain in Women During Smoking Cessation Is a Sex-Specific Predictor of 6-Month Abstinence: A Retrospective Cohort Study. Front Public Health. 2022;10:872220.

  4. Cropsey KL, Leventhal AM, Stevens EN, Trent LR, Clark CB, Lahti AC et al. Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine Tob Res. 2014;16:1174-82.

  5. Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014;371(25):2353-62.

  6. Rigotti NA, Benowitz NL, Prochaska J, Leischow S, Nides M, Blumenstein B et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023;330(2):152-160.

  7. Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP et al. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA. 2021;326(1):56-64.

  8. Rigotti NA, Benowitz NL, Prochaska JJ, Cain DF, Ball J, Clarke A et al. Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial. JAMA Intern Med. 2024;184(8):922-930.

  9. Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction. 2021;116(10):2847-2858.

  10. Asmoken (cytisinicline). Summary of Product Characteristics. Swedish Medical Products Agency [updated 2024-03-27, cited 2025-01-23]

  11. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2023 [cited 2024-03-06.]

  1. Manns A, Torregrossa H, Mahdjoub S, Gomajee R, Melchior M, El-Khoury Lesueur F. Do Determinants of Smoking Cessation and Relapse Differ between Men and Women? Data from a French National Study. Subst Use Misuse. 2024;59(2):167-176.
  2. Swan GE, Javitz HS, Jack LM, Curry SJ, McAfee T. Heterogeneity in 12-month outcome among female and male smokers. Addiction. 2004;99:237-50.
  3. Kuo CW, Lin CF, Chen CY, Wang RH, Chou CY, Cheng HJ et al. Body-Weight Gain in Women During Smoking Cessation Is a Sex-Specific Predictor of 6-Month Abstinence: A Retrospective Cohort Study. Front Public Health. 2022;10:872220.
  4. Cropsey KL, Leventhal AM, Stevens EN, Trent LR, Clark CB, Lahti AC et al. Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine Tob Res. 2014;16:1174-82.
  5. Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014;371(25):2353-62.
  6. Rigotti NA, Benowitz NL, Prochaska J, Leischow S, Nides M, Blumenstein B et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023;330(2):152-160.
  7. Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP et al. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA. 2021;326(1):56-64.
  8. Rigotti NA, Benowitz NL, Prochaska JJ, Cain DF, Ball J, Clarke A et al. Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial. JAMA Intern Med. 2024;184(8):922-930.
  9. Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction. 2021;116(10):2847-2858.
  10. Asmoken (cytisinicline). Summary of Product Characteristics. Swedish Medical Products Agency [updated 2024-03-27, cited 2025-01-23]
  11. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2023 [cited 2024-03-06.]